NCT06581796View on ClinicalTrials.gov

Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 10, 2024

Study Completion Date

November 21, 2024

Conditions
Hyperemesis GravidarumPregnant With Complication
Interventions
OTHER

pepsinogen-1

association between pepsinogen 1 serum level with hyperemesis gravidarum

Trial Locations (1)

Unknown

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06581796 - Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum | Biotech Hunter | Biotech Hunter